🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open-label, single-arm Phase Ib/II clinical trial designed...
Status
Unknown
Location
Hubei Cancer Hospital
Start Date
2023-12-12
Trial ID
NCT06224842
Study Objectives: To evaluate the Relapse-Free Survival (RFS) and 1-year R...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technolog
Start Date
2026-06-01
Trial ID
NCT07521124
For the first 28 day cycle, all patients will be treated with single agent ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-06
Trial ID
NCT02564536
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of ASTX727...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2026-06-09
Trial ID
NCT07012044
The main objective of this study was to assess the safety profile of MBG453...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2022-03-17
Trial ID
NCT04878432
Treatments Being Tested
A multi-center, open-label phase I/II study to to determine the safety and ...
Status
Completed
Location
Uniklinik Köln
Start Date
2020-05-25
Trial ID
NCT04257448
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03390296
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, w...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 233179
Start Date
2022-01-06
Trial ID
NCT05144243
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and clinica...
Status
Completed
Location
University of Texas MD Anderson Cancer Center Department of Leukemia, Division of Cancer Medicine
Start Date
2021-02-17
Trial ID
NCT04629443
Treatments Being Tested
Brief Scientific Rationale: Decitabine has been shown to be effective for ...
Status
Unknown
Location
Seoul St. Mary's Hospital
Start Date
2011-01
Trial ID
NCT01277484
Treatments Being Tested